Guaifenesin Extended-Release 1200 mg
NDC 53041-234, Guaifenesin, tablet, extended release, from Guardian Drug Company.
- Product NDC
- 53041-234
- Status
- Listed
- Labeler
- Guardian Drug Company
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA209215
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/53041-234 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN1200 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 53041-234-37 | 53041023437 | 4 BLISTER PACK in 1 CARTON (53041-234-37) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
| 53041-234-47 | 53041023447 | 6 BLISTER PACK in 1 CARTON (53041-234-47) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
| 53041-234-58 | 53041023458 | 2 BLISTER PACK in 1 CARTON (53041-234-58) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 53041-234 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/53041-234 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 53041-234. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.